Discovery & Innovation

Three outstanding examples for fragment-based drug discovery A good example for the reliability of the fragment-based screening method is the...

Directed evolution is emerging as a powerful new tool to design proteins with new and interesting properties that may not have evolved naturally...

Illumina recently announced the $1000 solution for the sequencing of the human genome in the form of its new instrument, the HiSeqX. This system...

The selection and accumulation of desirable mutations – also known as natural selection – has shaped the living world. The proteins resulting from...

One major challenge in drug discovery is determining whether a drug is behaving as intended, binding the “right” protein, inhibiting the correct...

This is Part 3 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 1 and Part 2). Big Data — the vast amount...

This is Part 2 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 1 and Part 3). Recent medical technology...

This is Part 1 in a three-part series on Big Data in the pharma and biotech industries. (Check out Part 2 and Part 3). Medical research and...

The need for CNS therapeutics is on the rise. Neurological diseases are expected to increase steadily in the coming years. Previously, we addressed...

More than $2 trillion dollars a year are spent on treatments for CNS disorders. One in three people over 80 currently has Alzheimer’s disease. With...